Catalyst
Slingshot members are tracking this event:
Phase 3 data of Neratinib in Third-line HER2-positive metastatic breast cancer due 1st half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PBYI |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 08, 2017
Occurred Source:
http://www.pumabiotechnology.com/pr20170908.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Neratinib, Her2-positive Breast Cancer
